AstraZeneca shares rise to top of FTSE 100 as COPD drug clears two pivotal trials Proactive uses images sourced from Shutterstock AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares rose 3% to 14,230p, ...
The FTSE 100 underperformed European peers on Monday as heavy falls in AstraZeneca outweighed more optimistic noises in the Middle East. The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On 18 June AstraZeneca said that the U.S. Food and Drug Administration cleared an Imfinzi combination regimen as the first immunotherapy-based option for BCG-naive high-risk non-muscle-invasive ...
AstraZeneca (US6549022043) remains one of the largest pharmaceutical groups on the London Stock Exchange, with its primary listing in the FTSE 100 and a broad global footprint in prescription ...
(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the Middle East. The FTSE 100 closed down 16.59 points ...
(Reuters) -Britain's FTSE 100 closed at a record high for the second straight session on Tuesday, as weak UK labour market data boosted hopes for Bank of England rate cuts and drugmaker AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results